ビタミンD療法の世界市場規模調査＆予測：投与経路別、購入パターン別、用途別、年齢層別、地域別分析、2023-2030年

世界のビタミンD療法市場は、2022年に約45億9,000万米ドルと評価され、予測期間2023-2030年には11.6％以上の健全な成長率で成長すると予測されています。

ビタミンD療法は、ビタミンD不足に関連する健康上の問題を緩和または監督するために、ビタミンDサプリメントまたは治療法を使用することを含みます。ビタミンD療法は、経口サプリメント、注射、その他の方法で行われ、個々のニーズと病歴に基づいて処方され、多くの場合、臨床検査によって導かれます。ビタミンD療法は、日光浴が制限されている人、食事によるビタミンD不足の人、ビタミンD吸収不良の人、特定の病状のある人に有効です。ビタミンD療法は、骨粗鬆症、くる病、自己免疫疾患、心血管疾患などの予防や管理に役立ちます。安全で効果的な結果を得るために、ヘルスケア専門家がビタミンD療法を監督し、適切な投与量と毒性を避けるためのモニタリングを重視しています。政府や製造業者によるビタミンD欠乏症に関する啓蒙活動やイニシアチブの増加、慢性疾患の罹患率の上昇、予防医療に対する消費者の嗜好の高まりは、世界中で市場の需要を促進している最も顕著な要因です。

加えて、座りがちな生活習慣を持つ膨大な患者プールと急速に増加する高齢化人口が、かなりの割合で市場需要の触媒として作用しています。高齢化社会では、皮膚合成の低下や運動能力の低下によりビタミンD欠乏症になりやすく、高齢者のビタミンD補充や治療の必要性が高まっています。世界保健機関（WHO）によると、2020年には世界の高齢化人口は10億人に達し、2030年には15億人に達すると予測されています。さらに、製剤技術の進歩や研究開発への投資の増加は、予測期間中に様々な有利な機会をもたらします。しかし、強化製品の消費の増加と規制シナリオの変化が、2023-2030年の予測期間を通じて市場の成長を妨げています。

ビタミンD療法の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、ビタミンD欠乏症に対する認識の高まり、有効性を向上させたより患者に優しい製品を開発するための広範な研究開発、医療費の増加により、2022年の市場を独占しました。また、身体活動の低下、肥満、社会的地位の低下はビタミンDレベルの低下と関連しています。例えば、2022年1月のCDCの報告では、アメリカ成人の25％が健康維持のために十分な身体活動をしていないことが明らかになった。身体活動不足の割合は州や地域によって異なり、コロラド州の17.7％からプエルトリコの49.4％まで幅があります。このような身体活動の低下は、個人のビタミンD欠乏症のリスクを高め、潜在的に治療需要を煽り、市場拡大を後押しします。一方、アジア太平洋地域は予測期間中最も高いCAGRで成長すると予想されます。ビタミンD欠乏症に関する意識の高まりと、ビタミンD欠乏症に対処するための治療計画を実施することを目的とした支援的な政府の取り組みが、この地域全体の市場需要を大幅に促進しています。さらに、著しい大気汚染レベル、座りがちなライフスタイル、ビタミンD欠乏症の発生率の上昇、型にはまった食生活、日光浴の減少、栄養不良レベルの上昇などの要因が、この地域におけるビタミンD欠乏症治療に対する需要の増加に寄与しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のビタミンD療法市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の発展
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 ビタミンD療法の世界市場力学

• ビタミンD療法市場の影響分析（2020～2030年）
  • 市場促進要因
    • 座りがちな生活習慣を持つ膨大な患者層と急速に増加する高齢化人口
    • 慢性疾患の増加
  • 市場の課題
    • 強化製品の消費拡大
    • 規制シナリオの変化
  • 市場機会
    • 製剤技術の進歩の高まり
    • 研究開発投資の増加

第4章 ビタミンD療法の世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 ビタミンD療法の世界市場：投与経路別

• 市場スナップショット
• ビタミンD療法の世界市場：投与経路別実績 - ポテンシャル分析
• ビタミンD療法の世界市場：投与ルート別推定・予測、2020～2030年
• ビタミンD療法市場：サブセグメント別分析
  • 経口投与ルート
  • 非経口投与ルート

第6章 ビタミンD療法の世界市場：購買パターン別

• 市場スナップショット
• ビタミンD療法の世界市場：購入パターン別実績 - ポテンシャル分析
• ビタミンD療法の世界市場：購入パターン別推定・予測、2020～2030年
• ビタミンD療法市場：サブセグメント分析
  • OTC医薬品
  • 処方薬

第7章 ビタミンD療法の世界市場：用途別

• 市場スナップショット
• ビタミンD療法の世界市場：用途別実績 - ポテンシャル分析
• ビタミンD療法の世界市場：用途別推定・予測、2020～2030年
• ビタミンD療法市場：サブセグメント別分析
  • 骨粗鬆症
  • くる病
  • 皮膚疾患
  • 筋力低下
  • 自己免疫疾患
  • その他の用途

第8章 ビタミンD療法市場：年齢層別

• 市場スナップショット
• ビタミンD療法の世界市場：年齢層別、実績 - ポテンシャル分析
• ビタミンD療法の世界市場：年齢層別推定・予測、2020～2030年
• ビタミンD療法市場：サブセグメント別分析
  • 小児
  • 成人
  • 高齢者

第9章 ビタミンD療法の世界市場：地域別分析

• 主要国
• 主な新興国
• ビタミンD療法市場：地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州のビタミンD療法市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のビタミンD療法市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのビタミンD療法市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Abbott Laboratories（US）
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Sanofi SE（France）
  • GlaxoSmithKline plc（UK）
  • Pfizer Inc.（US）
  • Merck & Co., Inc.（US）
  • Torrent Pharmaceuticals Ltd.（India）
  • Novartis International AG（Switzerland）
  • Alkem Laboratories（India）
  • Sun Pharmaceutical Industries Ltd.（India）
  • Cadila Healthcare Ltd（India）

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Vitamin D Therapy Market, report scope
• TABLE 2. Global Vitamin D Therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Vitamin D Therapy Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
• TABLE 4. Global Vitamin D Therapy Market estimates & forecasts by Purchasing Pattern 2020-2030 (USD Billion)
• TABLE 5. Global Vitamin D Therapy Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 6. Global Vitamin D Therapy Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
• TABLE 7. Global Vitamin D Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Vitamin D Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Vitamin D Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Vitamin D Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Vitamin D Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Vitamin D Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Vitamin D Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Vitamin D Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Vitamin D Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. Global Vitamin D Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 18. U.S. Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. U.S. Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 21. Canada Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. Canada Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 24. UK Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. UK Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 27. Germany Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. Germany Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 30. France Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. France Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 33. Italy Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Italy Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 36. Spain Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. Spain Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 39. RoE Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. RoE Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 42. China Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. China Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 45. India Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. India Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 48. Japan Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. Japan Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 51. South Korea Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. South Korea Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 54. Australia Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. Australia Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. RoAPAC Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 60. Brazil Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Brazil Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 63. Mexico Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. Mexico Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 66. RoLA Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. RoLA Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. Saudi Arabia Vitamin D Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 69. South Africa Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. RoMEA Vitamin D Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global Vitamin D Therapy Market
• TABLE 72. List of primary sources, used in the study of global Vitamin D Therapy Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Vitamin D Therapy Market, research methodology
• FIG 2. Global Vitamin D Therapy Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Vitamin D Therapy Market, key trends 2022
• FIG 5. Global Vitamin D Therapy Market, growth prospects 2023-2030
• FIG 6. Global Vitamin D Therapy Market, porters 5 force model
• FIG 7. Global Vitamin D Therapy Market, pest analysis
• FIG 8. Global Vitamin D Therapy Market, value chain analysis
• FIG 9. Global Vitamin D Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Vitamin D Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Vitamin D Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Vitamin D Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Vitamin D Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Vitamin D Therapy Market, regional snapshot 2020 & 2030
• FIG 15. North America Vitamin D Therapy Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Vitamin D Therapy Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Vitamin D Therapy Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Vitamin D Therapy Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Vitamin D Therapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Vitamin D Therapy Market is valued approximately at USD 4.59 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.6% over the forecast period 2023-2030. Vitamin D therapy involves to the usage of vitamin D supplements or therapeutic methods to mitigate deficits or oversee health issues related to insufficient amounts of vitamin D. It aims to restore optimal vitamin D levels crucial for bone health, immune function, and overall well-being. Administered through oral supplements, injections, or other forms, vitamin D therapy is prescribed based on individual needs and medical history, often guided by laboratory tests. It is beneficial for populations with limited sun exposure, dietary deficiencies, malabsorption issues, or certain medical conditions. The therapy helps prevent or manage conditions such as osteoporosis, rickets, autoimmune disorders and cardiovascular diseases. Healthcare professionals oversee vitamin D therapy to ensure safe and effective outcomes, emphasizing proper dosage and monitoring to avoid toxicity. The increase in awareness campaigns and initiatives about vitamin D deficiency by the government and manufacturers, rise in incidences of the chronic diseases, and rising consumer preference for preventive healthcare are the most prominent factors that are propelling the market demand across the globe.

In addition, the huge patient pool with sedentary lifestyle and rapidly growing aging population is acting as a catalyzing factor for the market demand at a substantial rate. The aging population is more prone to vitamin D deficiency due to reduced skin synthesis and decreased mobility, increasing the need for vitamin D supplementation and therapy among older adults. According to the World Health Organization (WHO), in 2020, it was expected that aging people around the world accounted for 1 billion, which is projected to reach 1.5 billion by the year 2030 which represents 1 in 6 people are more than 60. Moreover, the rise in technological advancements in formulations, as well as the growing investments in research and development presents various lucrative opportunities over the forecasting years. However, the growing consumption of fortified products and the changes in regulatory scenario are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Vitamin D Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing awareness of vitamin D deficiency, extensive research to develop more patient-friendly products with improved efficacy and the rise in healthcare spending. Also, the decreased physical activity, obesity, and lower social status are associated with low vitamin D levels. For instance, a CDC report from January 2022 revealed that 25% of American adults do not engage in sufficient physical activity for maintaining health. Physical inactivity rates vary across states and territories, ranging from 17.7% in Colorado to 49.4% in Puerto Rico. This decline in physical activity heightens the risk of vitamin D deficiency among individuals, potentially fueling the demand for treatment and bolstering market expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing awareness regarding vitamin D deficiency and bolstered by supportive government initiatives aimed at implementing treatment plans for addressing vitamin D deficiency are significantly propelling the market demand across the region. Additionally, factors such as significant air pollution levels, sedentary lifestyles, escalating incidence of vitamin D deficiency, unconventional dietary habits, reduced sun exposure, and rising malnutrition levels contribute to the increasing demand for vitamin D deficiency treatment in the region.

Major market players included in this report are:

• Abbott Laboratories (US)
• Sanofi SE (France)
• GlaxoSmithKline plc (UK)
• Pfizer Inc. (US)
• Merck & Co., Inc. (US)
• Torrent Pharmaceuticals Ltd. (India)
• Novartis International AG (Switzerland)
• Alkem Laboratories (India)
• Sun Pharmaceutical Industries Ltd. (India)
• Cadila Healthcare Ltd (India)

Recent Developments in the Market:

• In August 2022, Arbro Pharmaceuticals introduced Vkap-D3, a plant-based capsule, in India. With a potency of 60,000 IU of Vitamin D3, Vkap-D3 is involved in a unique hard vegetarian liquid-filled capsule shell made of plant-based HPMC. This novel combination is intended to effectively treat vitamin D deficiencies.

Global Vitamin D Therapy Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Route of Administration, Purchasing Pattern, Application, Age Group, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

• Oral Route
• Parenteral Route

By Purchasing Pattern:

• OTC Drugs
• Prescription Drugs

By Application:

• Osteoporosis
• Rickets
• Skin Diseases
• Muscle Weakness
• Autoimmune Disorders
• Other Applications

By Age Group:

• Children
• Adults
• Senior Adults

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Vitamin D Therapy Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Vitamin D Therapy Market, by Route of Administration, 2020-2030 (USD Billion)
  • 1.2.3. Vitamin D Therapy Market, by Purchasing Pattern, 2020-2030 (USD Billion)
  • 1.2.4. Vitamin D Therapy Market, by Application, 2020-2030 (USD Billion)
  • 1.2.5. Vitamin D Therapy Market, by Age Group, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Vitamin D Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Vitamin D Therapy Market Dynamics

• 3.1. Vitamin D Therapy Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Huge patient pool with sedentary lifestyle and rapidly growing aging population
    • 3.1.1.2. Rising incidences of the chronic diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Growing consumption of fortified products
    • 3.1.2.2. Changes in regulatory scenario
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rise in technological advancements in formulations
    • 3.1.3.2. Growing investments in research and development

Chapter 4. Global Vitamin D Therapy Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Vitamin D Therapy Market, by Route of Administration

• 5.1. Market Snapshot
• 5.2. Global Vitamin D Therapy Market by Route of Administration, Performance - Potential Analysis
• 5.3. Global Vitamin D Therapy Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
• 5.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 5.4.1. Oral Route
  • 5.4.2. Parenteral Route

Chapter 6. Global Vitamin D Therapy Market, by Purchasing Pattern

• 6.1. Market Snapshot
• 6.2. Global Vitamin D Therapy Market by Purchasing Pattern, Performance- Potential Analysis
• 6.3. Global Vitamin D Therapy Market Estimates & Forecasts by Purchasing Pattern 2020-2030 (USD Billion)
• 6.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 6.4.1. OTC Drugs
  • 6.4.2. Prescription Drugs

Chapter 7. Global Vitamin D Therapy Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Vitamin D Therapy Market by Application, Performance - Potential Analysis
• 7.3. Global Vitamin D Therapy Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 7.4.1. Osteoporosis
  • 7.4.2. Rickets
  • 7.4.3. Skin Diseases
  • 7.4.4. Muscle Weakness
  • 7.4.5. Autoimmune Disorders
  • 7.4.6. Other Applications

Chapter 8. Vitamin D Therapy Market, by Age Group

• 8.1. Market Snapshot
• 8.2. Global Vitamin D Therapy Market by Age Group, Performance - Potential Analysis
• 8.3. Global Vitamin D Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
• 8.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 8.4.1. Children
  • 8.4.2. Adults
  • 8.4.3. Senior Adults

Chapter 9. Global Vitamin D Therapy Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Vitamin D Therapy Market, Regional Market Snapshot
• 9.4. North America Vitamin D Therapy Market
  • 9.4.1. U.S. Vitamin D Therapy Market
    • 9.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Purchasing Pattern breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. Age Group breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Vitamin D Therapy Market
• 9.5. Europe Vitamin D Therapy Market Snapshot
  • 9.5.1. U.K. Vitamin D Therapy Market
  • 9.5.2. Germany Vitamin D Therapy Market
  • 9.5.3. France Vitamin D Therapy Market
  • 9.5.4. Spain Vitamin D Therapy Market
  • 9.5.5. Italy Vitamin D Therapy Market
  • 9.5.6. Rest of Europe Vitamin D Therapy Market
• 9.6. Asia-Pacific Vitamin D Therapy Market Snapshot
  • 9.6.1. China Vitamin D Therapy Market
  • 9.6.2. India Vitamin D Therapy Market
  • 9.6.3. Japan Vitamin D Therapy Market
  • 9.6.4. Australia Vitamin D Therapy Market
  • 9.6.5. South Korea Vitamin D Therapy Market
  • 9.6.6. Rest of Asia Pacific Vitamin D Therapy Market
• 9.7. Latin America Vitamin D Therapy Market Snapshot
  • 9.7.1. Brazil Vitamin D Therapy Market
  • 9.7.2. Mexico Vitamin D Therapy Market
• 9.8. Middle East & Africa Vitamin D Therapy Market
  • 9.8.1. Saudi Arabia Vitamin D Therapy Market
  • 9.8.2. South Africa Vitamin D Therapy Market
  • 9.8.3. Rest of Middle East & Africa Vitamin D Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Abbott Laboratories (US)
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Sanofi SE (France)
  • 10.3.3. GlaxoSmithKline plc (UK)
  • 10.3.4. Pfizer Inc. (US)
  • 10.3.5. Merck & Co., Inc. (US)
  • 10.3.6. Torrent Pharmaceuticals Ltd. (India)
  • 10.3.7. Novartis International AG (Switzerland)
  • 10.3.8. Alkem Laboratories (India)
  • 10.3.9. Sun Pharmaceutical Industries Ltd. (India)
  • 10.3.10. Cadila Healthcare Ltd (India)

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption